|Bid||19.25 x 800|
|Ask||57.13 x 800|
|Day's range||47.32 - 48.65|
|52-week range||21.06 - 66.47|
|Beta (5Y monthly)||0.46|
|PE ratio (TTM)||N/A|
|Earnings date||23 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||84.60|
DUBLIN, Ireland, March 21, 2023--Prothena announced today that members of its senior management team will participate in a fireside chat at Stifel 2023 Virtual CNS Days on March 28 .
DUBLIN, March 14, 2023--Prothena announced broad participation at AD/PD 2023 highlighting leadership in advancing treatments for Alzheimer’s and Parkinson’s disease
Prothena (PRTA) reports better-than-expected results for the fourth quarter. The company makes considerable pipeline progress.